Transfer-factor therapy in multiple sclerosis

Lancet. 1976 May 8;1(7967):988-90. doi: 10.1016/s0140-6736(76)91861-4.

Abstract

The effect of transfer factor prepared from relatives of patients with multiple sclerosis (M.S.) and from unrelated donors on the clinical course of M.S. has been studied in fifteen male and fifteen female patients. Some patients were given transfer factor and some placebo (physiological saline). Results of three independent clinical examinations by different neurologists and subjective assessments by the patients showed no difference between those given transfer factor and those given placebo.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Clinical Trials as Topic
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Immunoglobulin G / analysis
  • Male
  • Middle Aged
  • Multiple Sclerosis / cerebrospinal fluid
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / therapy*
  • Transfer Factor / therapeutic use*

Substances

  • Immunoglobulin G
  • Transfer Factor